Clinical trial · Interventional
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening
NCT04675476CI-TRIAL-00084141recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Provider Prompt & Patient Outreach and Education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Multilevel Intervention
- interventionNames
- Behavioral: Provider Prompt & Patient Outreach and Education
- type
- NO_INTERVENTION
- label
- Nonequivalent Control Group
Primary outcomes (3)
- measure
- provider-patient discussion
- timeFrame
- 1-week post-visit
- description
- Discussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')
- measure
- lung cancer screening intentions
- timeFrame
- 1-week post-visit
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * 50-80 years old; * current cigarette smoker or quit within 15 years; * a 20+ pack-year smoking history; * non-adherent to lung screening (\>13 months); * English-speaking; * scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and * able and willing to provide meaningful consent and complete telephone interviews Exclusion Criteria: * Individuals with a history of lung cancer
References
Publications (2)
- DERIVEDWilliams RM, Whealan J, Sangraula A, Taylor KL, Adams-Campbell L, Miller KE, Glassmeyer K, Yee P, Camidge K, Foley K, Luta G, Lin KW, Barnes R, DuBoyce WF. Providing Reminders and Education Prior to lung cancer screening: Feasibility and acceptability of a multilevel approach to address disparities in lung cancer screening. Transl Behav Med. 2025 Jan 16;15(1):ibaf008. doi: 10.1093/tbm/ibaf008. PMID 40231692
- DERIVEDWilliams RM, Whealan J, Taylor KL, Adams-Campbell L, Miller KE, Foley K, Luta G, Brandt H, Glassmeyer K, Sangraula A, Yee P, Camidge K, Blumenthal J, Modi S, Kratz H. Multilevel approaches to address disparities in lung cancer screening: a study protocol. Implement Sci Commun. 2024 Feb 16;5(1):15. doi: 10.1186/s43058-024-00553-4. PMID 38365820